Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy
Page 1 of 1
Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy
Jon Moulton Wed Jul 16, 2014 11:27 am
Li J, Qi M, Li C, Shi D, Zhang D, Xie D, Yuan T, Feng J, Liu Y, Liang D, Xu X, Chen J, Xu L, Zhang H, Ye J, Lv F, Huang J, Peng L, Chen YH. Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy. Cell Res. 2014 Jul 15. doi: 10.1038/cr.2014.94. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
» A Long Noncoding RNA, CHRF Regulates Cardiac Hypertrophy by Targeting miR-489
» Developmental cardiac hypertrophy in a mouse model of prolidase deficiency
» RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure
» Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction
» A Long Noncoding RNA, CHRF Regulates Cardiac Hypertrophy by Targeting miR-489
» Developmental cardiac hypertrophy in a mouse model of prolidase deficiency
» RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure
» Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum